dr. kristeleit on the safety profile of rucaparib in ovarian cancer
Published 7 years ago • 299 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:17
dr. kristeleit on the efficacy of rucaparib in ovarian cancer
-
1:14
dr. coleman on benefit of rucaparib in ovarian cancer
-
1:15
dr. birrer on fda approval of rucaparib in ovarian cancer
-
5:18
rucaparib for ovarian cancer
-
1:29
dr. monk on the fda approval of maintenance rucaparib in ovarian cancer
-
1:41
the clinical activity of rucaparib in patients with ovarian cancer
-
1:24
dr. coleman on the effect of age on the efficacy of rucaparib
-
6:12
rucaparib for recurrent ovarian cancer
-
0:46
dr. chase on toxicities with niraparib in ovarian cancer
-
1:10
dr. o'malley on fda approval of maintenance rucaparib in ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
0:49
dr. comerci on the use of laparoscopy in ovarian cancer
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
0:53
dr. annunziata on olaparib and cediranib combination in ovarian cancer
-
2:12
dr. patel on an analysis of olaparib and cediranib for ovarian cancer
-
2:05
dr. copeland on the etiology of ovarian cancer
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
0:58
dr. wingo on the evolution of surgery in patients with ovarian cancer
-
44:06
ovarian cancer: knowledge is power | presented by cailey crawford